Home/ Supplements/ Vitamin K/ Vitamin K2+D3

Vitamin K2+D3

product on market Tablet or Pill Source Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin D3 and K2 work synergistically to support bone health and calcium absorption, with strong evidence supporting their role in mineral density. Calcium provides the essential structural building blocks for skeletal integrity. Research indicates these ingredients are generally safe when taken within recommended dosages.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2+D3
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

10 mcg (50% DV)
Within RDA (0.7× RDA) 608 studies (A:16, B:251)
100 mcg (83% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)
Calcium
110 mg (8% DV)

Other Ingredients

Dibasic Calcium Phosphate Sorbitol Microcrystalline Cellulose Stearic Acid Silica Magnesium Stearate modified Cellulose Gum
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: 1 tablet daily, preferably with a meal.

Warnings & Precautions

Caution: If you are pregnant, may become pregnant, breastfeeding, or if you are taking anticoagulant drugs such as warfarin (Coumadin), consult a healthcare practitioner before using. Vitamin K2 may counteract the effects of anticoagulation therapy, and therefore is not recommended for patients on blood-thinning medications.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

Formulation Notes

100 mcg of MenaQ7 Vitamin K2 as MK-7 MK-7

Bone and heart health support

Source Naturals Vitamin K2+D3 combines two important nutrients that support bone and heart health. The MenaQ7 vitamin K2 in this product lasts up to 12 times longer in the body than other forms of vitamin K.

Contains no yeast, dairy, egg, gluten, soy or wheat. Contains no preservatives, or artificial color, flavor or fragrance.

Metadata

Product Details

UPC / SKU0 21078 01922 0
DSLD Entry Date2023-01-23
Product TypeOther Combinations
FormTablet or Pill
DSLD ID273496
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.